Finding early signs of memory loss in China
Part of Brain & nervous system, Mental health clinical trials.
This trial looks for new ways to diagnose memory and thinking problems earlier. It involves a memory test, brain scan, and blood draw to find markers that could help identify cognitive disorders.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 90 years old.
- You or someone close to you has noticed a decline in your memory or thinking.
- You can speak and understand Chinese.
- You are willing to sign a consent form and have a family member also agree.
- You do not have a very severe memory problem (score less than 10 on a standard test).
- You do not have other brain diseases (like Parkinson's, epilepsy, or a brain tumor) or serious health issues (like liver or kidney failure, severe anemia, or HIV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “biomarkers” (measurable signs from blood and brain tests) that may help predict who with mild cognitive impairment (MCI) could later develop dementia. Results may help doctors spot risk earlier and better plan care.
This study uses a digital tool to help detect early signs of Alzheimer's disease in people aged 50 and older. It aims to find high-risk individuals who may benefit from early monitoring.
This study looks at how people with thinking, memory, mood, or behavior problems fare over time. It may help doctors understand these conditions better and improve care.
This study aims to find early signs of Alzheimer's in the community through blood tests and assessments. It's for people who can think clearly and agree to participate without major health issues.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
This study is testing whether a simple blood draw can help spot early signs of Alzheimer's disease. It aims to include people from diverse backgrounds who do not currently have memory problems, which may help make early detection more accessible for everyone.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.